从百年工业巨头3M分拆独立后，医疗科技公司Solventum再次站到聚光灯下。 近日，Solventum发布2026年Q1财报，公司实现营收20.1亿美元，同比下降3%；净利润仅1300万美元，同比暴跌90.5%。而这份成绩单的复杂，远不止于数据下滑。一方面，调整后每股收益（EPS）达到1.48美元，超出华尔街分析师一致预期的1.35美元，营收亦高于预期的19.9亿美元；另一方面，GAAP口径下...
Source Link从百年工业巨头3M分拆独立后，医疗科技公司Solventum再次站到聚光灯下。 近日，Solventum发布2026年Q1财报，公司实现营收20.1亿美元，同比下降3%；净利润仅1300万美元，同比暴跌90.5%。而这份成绩单的复杂，远不止于数据下滑。一方面，调整后每股收益（EPS）达到1.48美元，超出华尔街分析师一致预期的1.35美元，营收亦高于预期的19.9亿美元；另一方面，GAAP口径下...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.